procure 2011 summer newsletter

8/6/2019 Procure 2011 Summer Newsletter

1/8

ANNOUNCEMENTS

SEPT. 17 CYCLOTRON TOURSOn Saturday, Sept. 17, rom 9:00 am to 1:00 pm, thpublic is invited to an open house and tour o thcyclotron in observance o Mens Health Day. Brin

your amily and riends to tour the ProCure ProtoTherapy Center in Oklahoma City, or to the CD

Proton Center, A ProCure Centerin Warrenville, IThe OKC event is being hosted in conjunction wiINTEGRIS Cancer Institute o Oklahoma around a

tivities such as ree prostate screenings and a livbroadcast o the Sports Animal.

SIGN UP FOR BOBBrotherhood o the Balloon, known as BOB or ProtoBob, is an organization ounded by Bob Marckini,

prostate patient treated with proton therapy at LomLinda 11 years ago. Bob created the organizatio

as a way to keep the ellowship going with the gooriends he made during treatment. Today, the BOorganization has grown to more than 5,300 mem

bers rom all over the world who have been treatewith proton therapy. Approximately 500 patienper year at Loma Linda have been reerred by BO

members. The voice o proton therapy treatment prostate cancer, BOB supports its members with th

latest news and research on proton therapy, cancer recurrence prevention, insurance coverage, diand liestyle tips, member reunions, member storie

and eedback ater fve, 10, 20 years ollowing treament, participation in surveys and access to resul

and much more. Get connected to this importaorganization and share your own stories and statistics. According to the American Cancer SocietResearch has shown that being part of a suppo

group following cancer treatment improves qua

ity of life, and enhances patient survival. Pleasvisit www.protonbob.com.

SPEAK FOR PROTONSMany o our patients are eager to help spread th

word about proton therapy, and how it has had suc

a positive eect on their health and quality o li

Some patients elect to speak on their own at churc

and civic unctions, and many ask us to participa

with them or the presentations. I you would like

speak and/or have a ProCure representative spea

with you, please contact Marcia Shields in Okla

homa City ([email protected], 40

773-6740) or Beverly Tanabe in Chicago (beverl

[email protected], 630-821-6403).

PROCURE CANCER FOUNDATIONThe ProCure Cancer Foundation provides support

proton radiation therapy patients in need o fnanci

assistance by unding non-medical expenses asso

ciated with the treatment to ensure access to th

improved quality o lie proton therapy enables. Th

oundation also supports patients at ProCure Proto

Therapy Centers and in non-ProCure proton trea

ment centers. For more inormation, to apply or

grant, or to donate, please visit http://www.proc

recancerfoundation.org.

Welcome to the frst issue o the ProCure Proton Therapy Centers newsletter. Wed

like to keep you up-to-date on center news and share some o our patient stories.

We hope to publish the newsletter quarterly and encourage you to submit ideas, your

stories and photos and eedback. Please send any ideas or suggestions to Marcia

Shields at [email protected].

SUMMER 2011

The CDH Proton Center,A ProCure Center, celebrated a major milestone July

14, as its 100th patient completed treatment or cancer at the states rst proton

therapy center. The patient, James Tonkin, 63, o Plaineld, Ill., was joined by

many o the Centers patients, riends and amily members during a graduation

ceremony with representatives rom Central DuPage Hospital (CDH), Radiation

Oncology Consultants and ProCure Treatment Centers.

We have been very

encouraged by thepositive results our

patients continue to

see, said William

Hartsell, M.D., medi-

cal director o the

CDH Proton Center,

A ProCure Center.

Although a majority

o our patients have

come rom nearby

cities and states,

we have been very

ortunate to be able

to oer the power

o proton therapy

to patients rom 12

states across the

country and over-

seas.

Since opening on October 19, 2010, the Center has used proton therapy to treat

patients with noncancerous tumors and cancerous tumors in the brain, central

nervous system, head and neck, lung, gastrointestinal tract and prostate, as well

as sarcomas and many pediatric cancers.

CHICAGO CENTER CELEBRATES

100 PATIENTS TREATED

South suburban mans graduation marksmilestone or Illinois frst proton therapy center

ProCure CEO Hadley Ford, Chicago ProCures 100th patient James Tonkin

& Chicago ProCure President Jim Williams
http://www.protonbob.com/mailto:beverly.tanabe%40chi.procure.com?subject=Message%20from%20Procure%20Newslettermailto:beverly.tanabe%40chi.procure.com?subject=Message%20from%20Procure%20Newsletterhttp://www.procurecancerfoundation.org/http://www.procurecancerfoundation.org/mailto:marcia.shields%40okc.procure.com?subject=Comment%20from%20newslettermailto:marcia.shields%40okc.procure.com?subject=Comment%20from%20newsletterhttp://www.procurecancerfoundation.org/http://www.procurecancerfoundation.org/mailto:beverly.tanabe%40chi.procure.com?subject=Message%20from%20Procure%20Newslettermailto:beverly.tanabe%40chi.procure.com?subject=Message%20from%20Procure%20Newsletterhttp://www.protonbob.com/


2/82 ProCure Proton Therapy Center

Beore Justin Rodriguez was diagnosed with cancer last Oc-

tober, his mother, Yasmin, considered him her rock. Raising

two other children with mental disorders, one diagnosed with

Aspergers syndrome and the other diagnosed with ADHD, six-

year-old Justin had always been the calming orce in her lie.

Justin was always my perectly healthy little boy, said Yasmin.

When he got sick it just turned our world upside down.

Last all Justin began having mood swings and suering rom

migraines and chronic atigue. Doctors in Lawton, Okla. origi-

nally diagnosed him with exhaustion, but Yasmin insisted it was

something else causing her sons illness.

On October 17, 2010 Justin was taken to the Childrens Hospi-

tal at OU Medical Center in Oklahoma City where they ound a

lemon-sized tumor in the middle o his brain. Five days later he

was diagnosed with having a malignant germ cell tumor causing spinal fuid build-up and pressure on his brain.

Justin immediately began a chemotherapy regimen, but ater ve rounds, his doctors decided it was ineective. The

tumor had now grown to the size o a baseball and needed to be removed immediately. More chemotherapy ollowed

beore Justin was sent to ProCure Proton Therapy Center in Oklahoma City or treatment.

The Rodriguez amily received a grant rom the ProCure Cancer Foundation, which provides support to proton radiation

therapy patients in need o nancial assistance. The grants und non-medical expenses associated with treatment to

ensure patients have access to the improved quality o lie proton therapy enables. For Yasmin, the grant meant more

unds available to house, eed and care or her husband and three children.

At the center, Justin and Yasmin ound more than just treatment or his cancer. According to Yasmin, they ound treat-

ment or their spirit as well.

The sta and other patients oster an environment where Justin could be Justin, said Yasmin. He went rom looking

and acting like a sick boy, to the Justin I remembered beore his diagnosis.

JUSTINS STORY: TREATMENT FOR CANCER AND SPIRIT

Justin Rodriguez & Nurse Pam Cannon

PROCURE HAS THE MAJORITY OF U.S. PROTON

CERTIFIED THERAPISTSProCures Training and Development Center (TDC) in Bloomington, Ind. is the only training acility in theworld dedicated to proton therapy. The TDC provides courseware to Ivy Tech Community College-

Bloomington, which provides accreditation and is the nations frst and only proton therapy certifcationprogram, operating as part o the colleges Radiation Therapy Program.

This month ProCure and Ivy Tech will graduate 12 additional therapists rom ProCures Chicago center

and six rom OKC, bringing the total number o graduates certifed in proton therapy to 65. O those65, 57 therapists are employed by ProCure. There are currently about 300 therapists working in proton

therapy, out o approximately 30,000 registered radiation therapists.

Beginning in 2012, the proton certifcation program will be oered publicly to any licensed radiation ther-

apist. For more inormation please visit www.ivytech.edu.
http://www.ivytech.edu/http://www.ivytech.edu/


3/8ProCure Proton Therapy Center 3

HELP OTHERS AND SHARE YOUR STORYTESTIMONIALS TO BE FILMED IN OKCRemember when you rst got your diagnosis? You were probably rightened, conused, and wanted all the inormation you could possibly nd. Weve heard

patients say the best source o inormation is that rom ormer patients who had the same questions and ears, did their research and are willing to discuss thei

journey. Every day there are hundreds o newly diagnosed cancer patients needing to hear your stories o survival, support and encouragement. You can help

On August 17 and 24, directly ollowing the graduation luncheon at the ProCure Proton Therapy Center in Oklahoma City, we will be lming patient testimonials

in a conerence room. We encourage you to tell your story. These short lm clips will be posted on our Website and available or those who need to hear rom

you. We will o course ask you to sign a release or permission to use your story. I you are interested please call 405-773-6740 or email [email protected] and well schedule your testimony. Please be sure to join us or lunch that day, or at any o our Wednesday graduation luncheons. View

other patient stories at http://www.procure.com/PatientStories.aspx.

At 92 years old, Rip VanWinkle was diagnosed with prostate cancer.

Because o his age, his primary physician and urologist told him he waslucky to have led such a long lie. They suggested he orgo treatment andhappily live out the remainder o his days.

This lack o treatment was not good enough or Rips wie, Elaine, whohad spent 45 years as a registered nurse. Familiar with the health systemand the obstacles they could ace while searching or the right treatment,Rip and Elaine looked to riends recently treated or prostate cancer orguidance.

This is both o our second marriages, and were just getting started,Elaine said. I need him around or a ew more years, not months.

Rip and Elaine rst sat down with two couples, o which the husbands

had recently gone through treatment or prostate cancer. One had cho-sen hormone therapy while the other chose traditional radiation therapy,and both couples were unhappy with the result. Both o these gentlemensuered serious side eects ater treatment and were unable to return tothe liestyles they led beore being diagnosed.

When they spoke to a third riend who was receiving proton therapy, Ripand Elaine were relieved to hear about a treatment that didnt seem toaect their riends quality o lie. Upon urther research, Rip and Elainedecided proton therapy was the best cancer treatment option or themto maintain their active liestyle.

With only seven proton therapy centers in the United Sates, Rip wasreerred to ProCure Proton Therapy Center in Oklahoma City where he

began treatment or his prostate cancer in February 2010.

During their time at the treatment center, Rip and Elaine made a lastingimpression with everyone who had the chance to meet them, and gener-ously spread the word about proton therapy to anyone who would listen.Between dancing twice a week with the OKC Swing Dance club, knittingscarves or every sta member at the center and religiously attending pa-tient luncheons and dine-arounds, Rip somehow managed to squeezehis treatments into his daily routine.

We think everyone we meet needs to know about the ProCure ProtonTherapy Center, and deserves the opportunity to come here, i they needit, he said.

RIP VANWINKLE, 92, DIDNT ACCEPT LIVE IT OUT

Rip VanWinkle
mailto:marcia.shields%40okc.procure.com?subject=Message%20from%20Newsletter%20Storymailto:marcia.shields%40okc.procure.com?subject=Message%20from%20Newsletter%20Storyhttp://www.procure.com/PatientStories.aspxhttp://www.procure.com/PatientStories.aspxmailto:marcia.shields%40okc.procure.com?subject=Message%20from%20Newsletter%20Storymailto:marcia.shields%40okc.procure.com?subject=Message%20from%20Newsletter%20Story


4/84 ProCure Proton Therapy Center

The rst pediatric patients rom the United Kingdom have recently completed their treatment at the ProCure Proton Therapy

Center in Oklahoma City. Leah Lilly Gillon, 22 months old rom Birmingham, England, and Thomas Adams, 24 months old

rom Liverpool, England, came to ProCure Proton Therapy Center in Oklahoma City. Their physicians in the UK had determined

traditional radiation was not an option or either o them due to their young age.

Because traditional radiation was not an option or either Lilly or Thomas, the National Health Service (NHS) in the UK deemedeach o them as candidates or proton therapy. Both Lilly and Thomas were at the Oklahoma center receiving proton therapy

treatment within three to our months ater their diagnosis.

UK PATIENTS HOP THE POND FOR PROTONS

THOMAS ADAMSThomas was diagnosed in January o 2011 with a rare brain tumor. His par-

ents, Ted and Rebecca, are both physicians and were dedicated to makingsure he received the best and most advanced treatment available. Ater two

operations and three months o ineective chemotherapy, the Adams were

granted unding rom the NHS or Thomas to receive proton therapy at Pro-

Cure Proton Therapy Center in Oklahoma City.

Although we are both physicians, we didnt entirely understand proton thera-

py, said Ted. But i it could help cure our son, we were determined to make

sure he received the most eective treatment possible.

Thomas arrived at the OKC center in June with his parents and a soon-to-be

little brother. Rebecca was eight months pregnant when they arrived, making

the situation that much more dicult.

Thomas and his parents welcomed his little brother, Inan, into the world in lateJune, and according to Thomas ather, they would return to the UK with three

incredible gits.

We let or home with a boy who is (hopeully) cured, a little baby and some

great new riends, said Ted. The American spirit o hospitality and all around

greatness has been evident in Oklahoma and at the ProCure Proton Therapy

Center. He added, Not many people will come to the United States and

go back with their own personal souvenir, but weve got one and his name

is Inan.

LILLY GILLONLilly was originally diagnosed in February with a ourth ventricle tumor. Following surgery and a shor

stint o chemotherapy, Lilly and her amily were on their way to Oklahoma City.

Lilly was initially accompanied by her mother, Cheria, and her Aunt Brenda while ather, Graham

stayed in England with Lillys three older sisters. When he joined them ater the rst hal o her treat-

ment schedule, Graham could not believe the transormation Lilly had taken in such a short time.

Ater Lilly had her tumor removed in February, she stopped eating, stopped speaking and stopped

walking. When I arrived in Oklahoma City I was delighted to see how happy and healthy she was,said Graham. She was walking and was denitely enjoying American ood, especially ries and

ranch sauce.

Lilly is now the happy child she was beore she was diagnosed with cancer, added Graham

When we return home, Ill be talking to anyone who will listen, including the NHS review board

about how brilliant this experience and these people have been at the treatment center in Okla-

homa City.

Lilly Gillon

Ted, Rebecca & Thomas Adams


5/8

FROM OUR PATIENTS

This poem was written and recited by Gordon Thorn

at his graduation ceremony at ProCure Proton Thera

Center in OKC.

PROTON BEAM

MY FAVORITE THINGSBy Gordon Thornhill

When the bell rings

When my pee stings

When Im eeling sad

I simply remember my avorite things

And then I dont eel so bad

Smiling aces about with the warmest o greetings

At the ront desk and at all o the meetings

They make me eel welcome and just like a king

These are a ew o my avorite things!

When my gown faps

Then my team claps

And Im eeling sad

I simply remember my avorite things

And then I dont eel so bad

Nurse Rachel with questions rom A to Z

How are eeling, do you have ED?

Water, more water til I could make springs

There are a ew o my avorite things

Merediths smile as she says Now be still

Lie on the table and dont be a pill

Lindsey is dancing as i she has wings

These are a ew o my avorite things.

When insurance says no!

Then Peggy re-loads

And says Dont eel so sad,

Just remember your avorite things

And I will go ater the cads!

Does this help your gol game? asks Matt and JohWith bubbly Jordan and Zanes steady brawn

Doctor Keoles examining

These are a ew o my avorite things

Now my cure comes!

I must leave soon

And Im eeling sad

But I will remember my avorite olks

And then I wont eel soooo bad!

Our patients say thanks or making the experience

as positive and pleasant as possible.

ProCure Proton Therapy Center 5

View Radiation Vacation, produced by OKC ProCure

graduates Gary Bridwell (Edmond, Okla.)

and Derek Rose (Las Vegas, Nev.):

View Here

Share Chicago graduate Martin Rhombergs journey

as he documents his experience and education

through proton therapy:

View Here

INKED FOR PROTONS

Former OKC ProCure patient Pete

Heggs rom Laramie, Wyo. shows

o his tattoo o the Bragg Peak,

captured in an Indian dream-

catcher with a hydrogen atom in

the middle. Omar Zeidan, P.h.D.,

director o medical physics in

OKC, provided consultation or the

design.
http://youtu.be/ZHTrdQNLVsghttp://web.me.com/martyrhomberg/Proton_Treatment/Welcome.htmlhttp://web.me.com/martyrhomberg/Proton_Treatment/Welcome.htmlhttp://youtu.be/ZHTrdQNLVsg


6/8

No area o our lives is as complex or mysterious as health insurance. Do you really understand what is covered, par

ticularly or complex diagnoses such as cancer? Have you really read your actual health insurance policy, and not just

the typical 20-page plan summary? Have you read all o the related documents, none o which are easily accessible

needed to understand your health insurance policy?

With private insurance, most large insurance companies cover and pay or proton therapy or many tumor sites.However, many o us have aced the rustration and extra eort required to obtain approval or coverage or have been

denied coverage when approval was initially sought. The ProCure nancial counselors work directly with patients and

are supported by experts within the company and across the country.

There are two major challenges or proton therapy with respect to insurance. The rst challenge is that insurance

companies do not like to pay or expensive services. The insurance companies deal with cancer patients who, and

rightully so, have a greater sense o urgency or treatment than most other types o patients. Cancer patients oten

are receiving conficting advice rom riends, amily and, too oten, physicians. Unortunately, because approval o

less expensive alternatives to proton therapy can be much quicker than or proton therapy, many patients give up

and accept what is easiest.

The second challenge is that, understandably, insurance companies do not want to pay or ineective care. Although

proton therapy has been used as a cancer treatment since the 1950s and was approved by Medicare in 1996, it is

still a rare orm o treatment. Fewer than 6,000 U.S. patients were treated with proton therapy in 2010 vs. more than

900,000 treated with other orms o radiation therapy. There are many types o cancer that can be treated eectively

with proton therapy. Because o the wide variety o tumor types that protons can treat, very ew cases o each type

are seen by most insurance companies. This results in payors inclination to conuse a rare treatment with an unprov

en treatment. This is especially true or cancers such as lung and breast tumors, which physicians at major academic

medical centers are only recently treating with proton therapy to greatly reduce side eects and improve quality o lie

We have made good strides with the insurance companies and most patients who come to us or proton therapy,

once our doctors determine they are in act proton therapy-appropriate patients, are able to attain coverage. Pro

Cure will continue to work closely with insurance plans and patients to ensure our patients have access to and cover

age or the best possible treatments. The extra eort up-ront provides a lietime o benets.

EXTRA EFFORT TO GET PROTON COVERAGE WILL YIELD LIFETIME OF BENEFITS

World-renowned or his expertise in proton radiotherapy, Dr. Eugen B. Hug is medical director and chie medi

cal ocer or ProCure Treatment Centers, Inc., overseeing medical operations, clinical research and treatmen

protocols or all o ProCures proton therapy centers in the United States. A pioneer in the use o proton therapy

or pediatric tumors, Dr. Hugs infuence in radiation oncology is elt worldwide. From the United States to Europe

to China, he has spent more than 20 years treating patients, conducting research, teaching and writing. He is

widely published in radiation oncology periodicals and books, authoring numerous journal articles or chapters. Ad

ditionally, he is a sought-ater lecturer and teacher at international medical meetings, symposia, and seminars. He

was principal or co-investigator o various clinical trials, including studies ocusing on proton therapy. His research

interests include ultra-precision radiation therapy and treatment o pediatric malignancies, connective tissue dis

ease and skull-base and central nervous system tumors. Twice he has been named as one o the Best Doctorsin America.

Prior to joining ProCure, Dr. Hug served as director o the Center or Proton Therapy at the Paul Scherrer Institute

in Villigen, Switzerland and as proessor and chair o proton-radiotherapy at the University o Zurich. He has held

various leadership roles in the past, including chie o the Section o Radiation Oncology at Dartmouth Hitchcock

Medical Center, and associate director o the NCI-designated Norris Cotton Cancer Center in Lebanon, N.H. He

has co-ounded the annual PSI Winterschool on proton therapy in Switzerland and co-chairs the annual ESTRO-Teaching course on protons and

ions in Europe. In addition, he presently co-chairs the educational subcommittee o the international Particle Therapy Co-Operative Group (PTCOG

including its annual seminar.

Dr. Hug received his medical degree rom Ludwig-Maximilians University Medical School in Munich, Germany, graduating summa cum laude. He

undertook postgraduate training in Germany and the United States, where he served as chie resident in the Department o Radiation Oncology at

Massachusetts General Hospital, Boston.

WORLD-RENOWNED RADIATION ONCOLOGIST JOINS PROCURE

6 ProCure Proton Therapy Center


7/8

SAMEER KEOLE, M.D.ProCure Proton Therapy Center, Oklahoma City, OK

Sameer Keole, M.D., is a partner at Radiation Medicine Associates (RMA) and the medical director at

the ProCure Proton Therapy Center, Oklahoma City. Prior to joining RMA and ProCure Proton Therapy

Center in Oklahoma, he spent our years treating patients and conducting research at the University o

Florida Proton Therapy Institute in Jacksonville, Fla., where he specialized in the treatment o pediatric

and prostate patients. While at the University o Florida Proton Therapy Institute, Dr. Keole also served as

an assistant proessor o medicine at the Shands Cancer Center at the University o Florida at Gainesville.

Ater completing his residency and serving as chie resident at the Wayne State University School o

Medicine, Detroit, Dr. Keole joined Academic Radiation Oncologists in Detroit. Dr. Keole completed

his undergraduate work at the University o Michigan, Ann Arbor, and received his M.D. rom the Ross

University School o Medicine, Commonwealth o Dominica, West Indies. He has authored more than

30 papers and abstracts and is sought-ater as a presenter at national and international oncology and

radiation conerences. Dr. Keole is a member o the American Society or Therapeutic Radiation, the

American Medical Association (AMA) and ASTRO (American Society o Therapeutic Radiation Oncology).

WILLIAM F. HARTSELL, M.D.CDH Proton Center,A ProCure Center, Chicago, IL

William Hartsell, M.D., is the president o Radiation Oncology Consultants (ROC) and the medical

director o the CDH Proton Center,A ProCure Center. He previously served as the medical director o

radiation oncology at Good Samaritan Cancer Center and Lutheran General Cancer Care Center. Dr.Hartsell joined ROC in 1997 ater completing his residency at Rush-Presbyterian St. Lukes Medical

Center in Chicago, where he spent six years as an assistant proessor and three years as director o

the residency program. He also served as an associate proessor and clinical director o the radiation

oncology program at the University o Tennessee, Memphis. Dr. Hartsell is a board-certied radiation

oncologist and specializes in brain tumors, pediatric tumors, head and neck cancers and lung cancer. He

earned his medical degree at the University o Oklahoma, Oklahoma City, and completed his internship

at Presbyterian-St. Lukes Medical Center in Denver. Dr. Hartsell has authored more than 120 papers on

topics including palliative care and the treatment o breast, brain, prostate, and head and neck cancers

and Hodgkin disease. He has also directed a number o national studies and participated in more than

70 visiting proessorships and guest lecture opportunities. Dr. Hartsell served on the Illinois board o

directors or the American Cancer Society or 10 years.

BRIAN H. CHON, M.D.ProCure Proton Therapy Center, Somerset, NJ

Brian H. Chon, M.D., is a radiation oncologist with Princeton Radiation Oncology in Princeton, N.J. andthe medical director at the ProCure Proton Therapy Center, Somerset, N.J. He graduated with honors

rom Swarthmore College, Philadelphia and received his medical degree rom Robert Wood JohnsonMedical School, New Brunswick, N.J. as a member o the esteemed Alpha Omega Alpha Society.

His residency was completed at the Massachusetts General Hospital o the Harvard Medical School inBoston where he was appointed chie resident in radiation oncology. Dr. Chon continued at Harvard,

advancing his medical career with a ellowship in science research on breast oncogenesis.He gained extensive proton therapy experience rom both the Harvard Cyclotron and the Burr ProtonTherapy Center at Massachusetts General Hospital with special expertise in cranial and extracranial

stereotactic radiation therapy as well as high-dose rate brachytherapy or thetreatment o gynecological and breast cancer.

In addition, Dr. Chon practices at Princeton Radiation Oncology Center in Monroe TWP, N.J.and currently has medical privileges at Hunterdon Regional Cancer Center in Flemington, N.J.,

CentraState Medical Center in Freehold, N.J.; St. Mary Medical Center in Langhorne, Pa.;and University Medical Center at Princeton in Princeton, N.J. He is a member o the

American Medical Association and the American Society or Therapeutic Radiation Oncology.

MEET OUR MEDICAL DIRECTORS


8/8

For questions about the following trials or about eligibility contact a ProCure Proton Therapy Center research nurs

Oklahoma City, Okla. Heather Perkins 405-773-6728

Warrenville, Ill. Peggy Wellman 630-821-6426

The following trial is currently open to cancer patients through ProCure Proton Therapy Center physician participa-

tion.

SUMMARYThe purpose o this study is to compare the eects (good and bad) on patients with prostate cancer by comparing the standard dose o ra

tion therapy (44 treatments over 8-9 weeks) with a higher daily dose o radiation (5 treatments over 1-2 weeks) to see i the eects o

treatments are similar or better

BASIC ELIGIBILITY CRITERIA:

INCLUSION CRITERIA:

Histologicallyconrmedprostateadenocarcinoma

HistologicalevaluationofprostatebiopsywithassignmentofaGleasonscoretothebiopsymaterial

PSAvalues

procure 2011 summer newsletter

Documents